Latest Pseudomembranous colitis Stories
A process involving transplanting poop to stop symptoms of a nasty disease has caused one woman to gain weight excessively.
Results indicate vaccine generates an immune response against key toxins in volunteers and establish dosing for Phase III BOSTON, May 19, 2014 /PRNewswire/ -- Sanofi Pasteur, the vaccines
A pilot study by Massachusetts General Hospital (MGH) investigators may lead to greater availability and acceptability of an unusual treatment for a serious medical problem – use of fecal material from healthy donors to treat recurrent diarrhea caused by the Clostridium difficile (C. difficile) bacteria.
WALTHAM, Mass., Jan. 29, 2014 /PRNewswire/ -- IMDx announced today that the artus C.
Vaccine Journal Publishes Study Documenting the Dose-Dependent Effect of HOWARU® Restore Kantvik, Finland (PRWEB) December 12, 2013 A study to investigate
Clostridium difficile, also known as "CDF/cdf", or "C. diff", is a Gram-positive bacteria of the genus Clostridium that causes severe diarrhea and other intestinal disease when competing bacteria in the gut flora are wiped out by antibiotics. They are anaerobic, spore-forming rods and is the most serious cause of antibiotic-associated diarrhea and potentially to pseudomembranous colitis. C. difficile bacteria naturally resides in the gut of a small percentage of the adult population. Others...